Prevalence and Severity of Depression Among Cardiothoracic Surgery Healthcare Workers in Baghdad:… (NCT06702761) | Clinical Trial Compass
RecruitingNot Applicable
Prevalence and Severity of Depression Among Cardiothoracic Surgery Healthcare Workers in Baghdad: A PHQ-9 Cross-Sectional Study
Iraq200 participantsStarted 2024-12-01
Plain-language summary
This observational study aims to estimate the prevalence and severity of depression in HCWs in cardiothoracic surgery departments in Baghdad City, Iraq, using a self-administered PHQ-9 questionnaire. The main questions it aims to answer are:
What is the prevalence of depression among cardiothoracic surgery healthcare workers? How is the severity of depression distributed within this group? Are there specific occupational or demographic factors associated with higher levels of depression?
Participants will:
Fill out the PHQ-9 in order to measure the severity of depressive symptoms at a specific moment in time.
Demographic and occupational details such as age, gender, years of experience and position held should be taken to look for possible relationship with depression.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Healthcare professionals actively working in cardiothoracic surgery departments in Baghdad, including surgeons, anesthesiologists, nurses, and support staff.
* Participants who provide informed consent for participation in the study.
* Able to complete questionnaire form.
Exclusion Criteria:
* Individuals with a previously diagnosed psychiatric condition other than depression that could confound the results.
* Incomplete or missing responses on the PHQ-9 questionnaire.
* Refusal to provide informed consent.
* Participants are currently undergoing treatment for depression or other mental health conditions.
* Healthcare workers on long-term leave or who have not actively worked in the cardiothoracic surgery department for the past 3 months.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Prevalence of Depression
Timeframe: Data collection will occur over a 3-months period, with each participant completing the assessment at a single point during this time frame.
2
Severity of Depression
Timeframe: Data collection will occur over a 3-months period, with each participant completing the PHQ-9 assessment at a single point during this time frame.
3
Patient Health Questionnaire-9 (PHQ-9)
Timeframe: Data collection will occur over a 3-months period, with each participant completing the PHQ-9 assessment at a single point during this time frame.